Healthcare provider profile · identity verified

Robert Woodward Bailey, M.D.

Family Practice · HENDERSONVILLE, NC · NPI 1609837079

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	472	125
Amlodipine Besylate	Amlodipine Besylate	396	119
Levothyroxine Sodium	Levothyroxine Sodium	267	79
Lorazepam	Lorazepam	265	68
Losartan Potassium	Losartan Potassium	235	74
Lisinopril	Lisinopril	229	74
Omeprazole	Omeprazole	221	72
Prednisone	Prednisone	209	154
Rosuvastatin Calcium	Rosuvastatin Calcium	204	63
Metformin Hcl	Metformin Hcl	199	59
Montelukast Sodium	Montelukast Sodium	186	64
Simvastatin	Simvastatin	176	50
Tamsulosin Hcl	Tamsulosin Hcl	169	54
Glipizide	Glipizide	156	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	153	25
Alprazolam	Alprazolam	151	23
Gabapentin	Gabapentin	140	44
Hydrochlorothiazide	Hydrochlorothiazide	132	42
Allopurinol	Allopurinol	130	36
Pantoprazole Sodium	Pantoprazole Sodium	130	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	112	33
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	111	99
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	111	33
Zolpidem Tartrate	Zolpidem Tartrate	103	28
Escitalopram Oxalate	Escitalopram Oxalate	102	30
Albuterol Sulfate Hfa	Albuterol Sulfate	96	32
Metoprolol Tartrate	Metoprolol Tartrate	94	30
Metoprolol Succinate	Metoprolol Succinate	92	31
Tramadol Hcl	Tramadol Hcl	85	26
Trazodone Hcl	Trazodone Hcl	82	25
Eliquis	Apixaban	80	24
Oxycodone Hcl	Oxycodone Hcl	78	11
Furosemide	Furosemide	71	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	65	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	29
Pravastatin Sodium	Pravastatin Sodium	60	16
Potassium Chloride	Potassium Chloride	56	11
Fluoxetine Hcl	Fluoxetine Hcl	55	23
Atenolol	Atenolol	54	17
Duloxetine Hcl	Duloxetine Hcl	53	16
Spironolactone	Spironolactone	50	12
Citalopram Hbr	Citalopram Hydrobromide	49	14
Gemfibrozil	Gemfibrozil	48	13
Memantine Hcl	Memantine Hcl	46	17
Meloxicam	Meloxicam	45	15
Alendronate Sodium	Alendronate Sodium	44	15
Glipizide-Metformin	Glipizide/Metformin Hcl	42	suppressed
Famotidine	Famotidine	41	suppressed
Sertraline Hcl	Sertraline Hcl	41	11
Metformin Hcl Er	Metformin Hcl	40	12
Diazepam	Diazepam	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	12
Clopidogrel	Clopidogrel Bisulfate	36	11
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	35	suppressed
Baclofen	Baclofen	34	suppressed
Clonazepam	Clonazepam	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	14
Carvedilol	Carvedilol	32	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	29
Finasteride	Finasteride	29	suppressed
Acyclovir	Acyclovir	28	11
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Ozempic	Semaglutide	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Azithromycin	Azithromycin	27	24
Paxlovid	Nirmatrelvir/Ritonavir	27	27
Synthroid	Levothyroxine Sodium	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	19
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	12
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Enalapril-Hydrochlorothiazide	Enalapril/Hydrochlorothiazide	19	suppressed
Estradiol	Estradiol	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Irbesartan	Irbesartan	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Carisoprodol	Carisoprodol	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	13
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Cephalexin	Cephalexin	13	12
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nystatin	Nystatin	13	suppressed
Fluconazole	Fluconazole	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error